95 related articles for article (PubMed ID: 18805502)
1. Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.
Yang S; Du J; Wang Z; Yan J; Yuan W; Zhang J; Zhu T
Int J Biochem Cell Biol; 2009 Apr; 41(4):853-61. PubMed ID: 18805502
[TBL] [Abstract][Full Text] [Related]
2. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
[TBL] [Abstract][Full Text] [Related]
3. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
[TBL] [Abstract][Full Text] [Related]
4. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH
Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
6. DeltaEF1 promotes breast cancer cell proliferation through down-regulating p21 expression.
Hu F; Wang C; Du J; Sun W; Yan J; Mi D; Zhang J; Qiao Y; Zhu T; Yang S
Biochim Biophys Acta; 2010 Feb; 1802(2):301-12. PubMed ID: 20006705
[TBL] [Abstract][Full Text] [Related]
7. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
[TBL] [Abstract][Full Text] [Related]
8. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process.
Sato MM; Nashimoto M; Katagiri T; Yawaka Y; Tamura M
Biochem Biophys Res Commun; 2009 May; 383(1):125-9. PubMed ID: 19341710
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
12. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
[TBL] [Abstract][Full Text] [Related]
14. miR-200b mediates post-transcriptional repression of ZFHX1B.
Christoffersen NR; Silahtaroglu A; Orom UA; Kauppinen S; Lund AH
RNA; 2007 Aug; 13(8):1172-8. PubMed ID: 17585049
[TBL] [Abstract][Full Text] [Related]
15. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
16. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
17. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death.
Raida M; Clement JH; Ameri K; Han C; Leek RD; Harris AL
Int J Oncol; 2005 Jun; 26(6):1465-70. PubMed ID: 15870857
[TBL] [Abstract][Full Text] [Related]
19. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
